Point72 Hong Kong LTD Maxcyte, Inc. Transaction History
Point72 Hong Kong LTD
- $1.5 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$21.2 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$17.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$11.7 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$10.6 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $215M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...